Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
RPTH Journal shared on LinkedIn about a recent article by Mosaad Almegren et al, adding:
”What’s the best anticoagulant for venous thrombosis in sickle cell disease?
Patients with sickle cell disease (SCD) face a high risk of venous thromboembolism, yet evidence guiding anticoagulation choice remains limited.
A new RPTH study compared direct oral anticoagulants (DOACs) vs warfarin in adults with SCD experiencing their first VTE.
Here’s the key signal:
- Similar rates of recurrent thrombosis and major bleeding between DOACs and warfarin.
- Clinically relevant non-major bleeding was significantly lower with DOACs.
Some context from the cohort:
- 99 patients with SCD and VTE
- Pulmonary embolism was the most common event (~65%)
- Median follow-up ~44 months
- Most DOAC use involved rivaroxaban or apixaban
Translation:
For patients with SCD and thrombosis, DOACs may offer comparable protection with less bleeding burden.
Big questions for the field:
- Should DOACs become first-line therapy for VTE in SCD?
- How long should anticoagulation continue in this high-recurrence population?
- Do SCD-specific thrombosis mechanisms require tailored anticoagulation strategies?”
Title: Management of venous thrombosis in sickle cell disease: a comparative study on the use of direct oral anticoagulants and warfarin
Authors: Mosaad Almegren, Eysa N. AlSolamy, Rayan A. Qutob, Mohammed M. Alasmari, Ali Aljeraiwi, Noura Aljuwaisri, Turki Abdulaziz Alshuaibi, Faisal Bahammam, Bader Al Rawahi, Hoor Hamed Al Farsi
Read the Full Article on RPTH
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience